Drug Substance Manufacturing

We have an exceptional range of flexible manufacturing equipment to ensure availability and suitability for our customers’ manufacturing needs.

With worldwide locations, an exemplary regulatory track record and a ‘can do’ approach, our experienced manufacturing teams will provide the competence, capacity and quality you expect to manufacture your product on time, on budget and to the very highest standards.  

"We can never complain about the quality of the deliverables; technical skills, communication, project management are some of the strong points for Hovione”

(US Biopharmaceutical, West Coast)

Hovione can reliably supply products from gram to ton quantities manufactured in modern, fully GMP compliant facilities. Our proven track record with the most demanding customers in the most regulated markets speaks for itself. We offer a broad range of capabilities, including potent compound handling, membrane purification techniques (up to production scale), cryogenic capacity (up to 10,000 litres and down to -100ºC), and hydrogenation (up to 5,000 litres and 60 bar). With manufacturing plants located across the globe, we operate 24/7 with dedicated  Quality Control support. All our sites are regularly inspected by health authorities and are approved to supply all major regulated markets, including the USA, Japan and Europe.

Highlight

Extensive manufacturing capacity

Hovione has sites in three continents each with distinctive capabilities

/hovione-worldwide

Also in Drug Substance

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page

Drug Substance Development

Talented people, smart processes and cutting-edge equipment – we have the perfect formula to meet all your process development and scale-up needs.

Page

Drug Substance Capabilities

Focused expertise in Drug Substance manufacturing processes.

Page

Drug Substance Technologies

We constantly innovate to find better, more efficient ways of doing things.

Page